|
|
Production and Characterization of Anti-OAS1 Monoclonal Antibody |
LI Zi1, BAO Xin-chen1, GAO Xiang-dong1, LU Xiao-dong2, XU Chen2 |
1. College of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China;
2. Beijing Tri-Prime Genetic Engineering Incorporated, Beijing 102600, China |
|
|
Abstract Aim: To detect OAS1, its monoclonal antibody was prepared by immune mouse. Methods: BALB/c female mice were immunized with His-OAS1 expressed by E.coli BL21 cells. Monoclonal antibody (McAb) was prepared by hybridoma technology. Identify the purity and characteristics of the selected McAb purified with saturated ammonium sulfate and give preliminary evaluation of the effectiveness of its application, in which SDS-PAGE, ELISA, Western blot and other methods were used. Results: High efficient expression of OAS1 protein in vivo, a McAb can detect the OAS1 was obtained designated as C24-5. The titer of C24-5-McAb was over 9×10-10mol/L, and the affinity constant of C24-5-McAb was 7.66×107 L·mol-1. Conclusion: The preparation of C24-5-McAb is very important to further improve the detection of OAS1.
|
Received: 03 May 2011
Published: 25 October 2011
|
|
|
|
[1] Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol, 2005, 5 (3): 215-229.
[2] Gish R G. Current treatment and future directions in the management of chronic hepatitis B viral infection. Clin Liver Dis, 2005, 9 (4): 541-565.
[3] Chebath J, Benech P, Hovanessian A, et al. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem, 1987, 262 (8):3852-3857.
[4] Hovanessian A G, Svab J, Marié I, et al. Characterization of 69-and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells. J Biol Chem, 1988, 263(10):4945-4949.
[5] Hovanessian A G. Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2',5'-oligoadenylate synthetases. J Interferon Res, 1991,11(4):199-205.
[6] Silverman R H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol, 2007, 81(23):12720-12729.
[7] 安萍,秦绍明,杨开宇,等. 慢性乙型肝炎病人注射α-干扰素后2-5AS活性动态变化及其临床意义. 天津医药,1995,23(3):147-149. An P,Qin S M,Yang K Y,et al. Tianjin Medical Journal,1995,23(3):147-149.
[8] Studier F W. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif, 2005, 41(1):207-234.
[9] Beatty J D, Beatty B G, Vlahos W G. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods, 1987, 100(1-2):173-179.
[10] Bingfa X, Qinglin F, Hui H, et al. Anti-hepatitis B virus activity and mechanisms of recombinant human serum albumin-interferon-alpha-2b fusion protein in vitro and in vivo. Pharmacology, 2009, 83(6):323-332.
[11] 吴诗品,苏冬娜.CHB患者PBMC中2-5AS基础活性对IFNα信号分子改变的影响.中华微生物学和免疫学杂志,2006,26(11):1026-1030. Wu S P,Su D N. Chinese Journal of Microbiology and Immunology,2006,26(11):1026-1030.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|